Precision Medicine

Nanomedicine could revolutionise the way we treat TB. Here’s how

At present, TB patients have to take multiple pills a day, often with significant side effects. Image: REUTERS/Mariana Bazo

Admire Dube

Associate Professor, Pharmaceutical Sciences, University of the Western Cape

Sarah D'Souza

Postdoctoral Fellow in the Tuberculosis Nanomedicine Research Group, University of the Western Cape


The Big Picture
Explore and monitor how Precision Medicine is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Precision Medicine

Image: WHO

Have you read?

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Precision MedicineHealth and HealthcareGlobal Health


Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda


You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

What are clinical trials and how do they work?
About Us
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum